OptMed Inc. (OMED) NASDAQ
$0.89 0 (0.00%)
Market Cap: $0
As of 04/22/19 04:00 PM EDT. Market closed.
OptMed Inc. (OMED)
NASDAQ
$0.89
0 (0.00%)
Market Cap: $0
As of 04/22/19 04:00 PM EDT. Market closed.
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
CEO Compensation (Base)
$419,777
URL
Address
.
PRICE CHART FOR OPTMED INC
From:
To:
NEWS
KEY STATS
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
0
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
0
Open in: 
Open in:
INSIDER TRANSACTIONS FOR OPTMED INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Gurney Austin | See Remarks | Dec 24, 2018 | Sale | $0.60 | 11,117 | 6,669 | 66,807 | Dec 26, 2018, 04:35 PM |
| Stagg Robert | SVP, Clinical R&D | Oct 10, 2018 | Sale | $2.01 | 927 | 1,863 | 40,670 | Oct 11, 2018, 07:00 PM |
| Li Yvonne | See Remarks | Oct 10, 2018 | Sale | $2.02 | 927 | 1,873 | 59,734 | Oct 11, 2018, 06:59 PM |
| Gurney Austin | See Remarks | Oct 10, 2018 | Sale | $2.01 | 1,156 | 2,324 | 77,924 | Oct 11, 2018, 06:57 PM |
| Hager Alicia J. | SVP & General Counsel | Oct 10, 2018 | Sale | $2.02 | 1,156 | 2,335 | 51,754 | Oct 11, 2018, 06:56 PM |
| Lewicki John A. | President & CEO | Oct 10, 2018 | Sale | $2.01 | 1,156 | 2,324 | 55,966 | Oct 11, 2018, 06:55 PM |
| Li Yvonne | See Remarks | Oct 09, 2018 | Sale | $2.13 | 1,229 | 2,616 | 60,661 | Oct 10, 2018, 07:44 PM |
| Gurney Austin | See Remarks | Oct 09, 2018 | Sale | $2.13 | 1,686 | 3,589 | 79,080 | Oct 10, 2018, 07:42 PM |
| Stagg Robert | SVP, Clinical R&D | Oct 09, 2018 | Sale | $2.13 | 1,686 | 3,589 | 41,597 | Oct 10, 2018, 07:41 PM |
| Lewicki John A. | President & CEO | Oct 09, 2018 | Sale | $2.13 | 2,296 | 4,888 | 57,122 | Oct 10, 2018, 07:40 PM |
| Hager Alicia J. | SVP & General Counsel | Oct 09, 2018 | Sale | $2.13 | 1,686 | 3,589 | 52,910 | Oct 10, 2018, 07:38 PM |
| Li Yvonne | See Remarks | Apr 24, 2018 | Sale | $2.68 | 5,062 | 13,555 | 59,890 | Apr 26, 2018, 06:14 PM |
| Stagg Robert | SVP, Clinical R&D | Apr 24, 2018 | Sale | $2.68 | 4,051 | 10,848 | 43,283 | Apr 26, 2018, 06:13 PM |
| Lewicki John A. | President & CEO | Apr 24, 2018 | Sale | $2.68 | 4,557 | 12,202 | 55,418 | Apr 26, 2018, 06:13 PM |
| Gurney Austin | See Remarks | Apr 24, 2018 | Sale | $2.68 | 4,051 | 10,848 | 76,766 | Apr 26, 2018, 06:12 PM |
| Hager Alicia J. | SVP & General Counsel | Apr 24, 2018 | Sale | $2.68 | 4,051 | 10,848 | 54,596 | Apr 26, 2018, 06:11 PM |
| Patel Sunil | See Remarks | Oct 10, 2017 | Sale | $4.24 | 1,248 | 5,295 | 69,538 | Oct 12, 2017, 06:36 PM |
| HASTINGS PAUL J | Chairman & CEO | Oct 10, 2017 | Sale | $4.24 | 1,398 | 5,931 | 77,534 | Oct 12, 2017, 06:35 PM |
| Lewicki John A. | EVP, Research & Development | Oct 10, 2017 | Sale | $4.24 | 1,248 | 5,295 | 71,614 | Oct 12, 2017, 06:35 PM |
| Gurney Austin | See Remarks | Oct 10, 2017 | Sale | $4.24 | 1,248 | 5,295 | 82,019 | Oct 12, 2017, 06:34 PM |
| Hager Alicia J. | SVP & General Counsel | Oct 10, 2017 | Sale | $4.24 | 1,248 | 5,295 | 59,849 | Oct 12, 2017, 06:33 PM |
| KARSEN PERRY A | Director | Jun 05, 2017 | Buy | $3.46 | 10,000 | 34,588 | 10,000 | Jun 07, 2017, 06:18 PM |
| LASERSOHN JACK W | Director | May 25, 2017 | Buy | $3.37 | 34,614 | 116,639 | 185,709 | May 26, 2017, 05:51 PM |
| ROOT JONATHAN D | Director | May 24, 2017 | Sale | $3.72 | 1,447 | 5,377 | 3,222 | May 26, 2017, 11:57 AM |
| ROOT JONATHAN D | Director | May 24, 2017 | Sale | $3.72 | 2,853 | 10,601 | 6,358 | May 26, 2017, 11:57 AM |
| ROOT JONATHAN D | Director | May 26, 2017 | Sale | $3.70 | 3,222 | 11,927 | 0 | May 26, 2017, 11:57 AM |
| ROOT JONATHAN D | Director | May 26, 2017 | Sale | $3.70 | 6,358 | 23,536 | 0 | May 26, 2017, 11:57 AM |
| LASERSOHN JACK W | Director | May 23, 2017 | Buy | $3.55 | 20,000 | 71,000 | 151,095 | May 25, 2017, 06:33 PM |
| ROOT JONATHAN D | Director | May 19, 2017 | Sale | $3.70 | 2,519 | 9,324 | 4,669 | May 22, 2017, 08:16 PM |
| ROOT JONATHAN D | Director | May 19, 2017 | Sale | $3.70 | 4,968 | 18,388 | 9,211 | May 22, 2017, 08:16 PM |
| LASERSOHN JACK W | Director | May 16, 2017 | Buy | $3.49 | 23,507 | 82,061 | 131,095 | May 18, 2017, 06:43 PM |
| ROOT JONATHAN D | Director | May 16, 2017 | Sale | $3.58 | 2,321 | 8,313 | 7,188 | May 18, 2017, 04:49 PM |
| ROOT JONATHAN D | Director | May 16, 2017 | Sale | $3.58 | 4,579 | 16,401 | 14,179 | May 18, 2017, 04:49 PM |
| Lewicki John A. | EVP, Research & Development | Apr 04, 2017 | Sale | $9.06 | 5,754 | 52,113 | 28,648 | Apr 05, 2017, 07:56 PM |
| Gurney Austin | See Remarks | Apr 04, 2017 | Sale | $9.06 | 5,754 | 52,113 | 49,012 | Apr 05, 2017, 07:41 PM |
| Patel Sunil | See Remarks | Apr 04, 2017 | Sale | $9.06 | 5,754 | 52,113 | 30,295 | Apr 05, 2017, 07:40 PM |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | Apr 04, 2017 | Sale | $9.06 | 5,754 | 52,113 | 62,936 | Apr 05, 2017, 07:40 PM |
| Hager Alicia J. | SVP & General Counsel | Apr 04, 2017 | Sale | $9.06 | 4,316 | 39,089 | 25,845 | Apr 05, 2017, 07:39 PM |
| HASTINGS PAUL J | Chairman & CEO | Apr 04, 2017 | Sale | $9.06 | 6,473 | 58,625 | 39,011 | Apr 05, 2017, 07:38 PM |
| Hager Alicia J. | SVP & General Counsel | Mar 15, 2017 | Option Exercise | $3.42 | 6,652 | 22,750 | 32,529 | Mar 17, 2017, 05:57 PM |
| Hager Alicia J. | SVP & General Counsel | Mar 15, 2017 | Sale | $10.00 | 6,652 | 66,520 | 25,877 | Mar 17, 2017, 05:57 PM |
| HASTINGS PAUL J | Chairman & CEO | Jan 05, 2017 | Option Exercise | $1.43 | 21,369 | 30,558 | 58,692 | Jan 09, 2017, 05:55 PM |
| HASTINGS PAUL J | Chairman & CEO | Jan 06, 2017 | Option Exercise | $1.43 | 21,369 | 30,558 | 58,692 | Jan 09, 2017, 05:55 PM |
| HASTINGS PAUL J | Chairman & CEO | Jan 06, 2017 | Sale | $8.52 | 21,369 | 181,957 | 37,323 | Jan 09, 2017, 05:55 PM |
| HASTINGS PAUL J | Chairman & CEO | Jan 05, 2017 | Sale | $8.17 | 21,369 | 174,602 | 37,323 | Jan 09, 2017, 05:55 PM |
| Lewicki John A. | EVP, Research & Development | Jan 03, 2017 | Option Exercise | $1.43 | 9,175 | 13,120 | 40,811 | Jan 05, 2017, 07:11 PM |
| Lewicki John A. | EVP, Research & Development | Jan 03, 2017 | Sale | $7.63 | 9,175 | 70,045 | 31,636 | Jan 05, 2017, 07:11 PM |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | Jan 03, 2017 | Option Exercise | $1.43 | 12,763 | 18,251 | 73,742 | Jan 05, 2017, 07:07 PM |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | Jan 03, 2017 | Sale | $7.64 | 12,763 | 97,448 | 60,979 | Jan 05, 2017, 07:07 PM |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | Nov 16, 2016 | Option Exercise | $1.43 | 12,500 | 17,875 | 73,479 | Nov 18, 2016, 06:21 PM |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | Nov 16, 2016 | Sale | $9.89 | 12,500 | 123,609 | 60,979 | Nov 18, 2016, 06:21 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jan 11, 2016 | Option Exercise | $4.56 | 2,500 | 11,400 | 23,142 | Jan 12, 2016, 05:38 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jan 11, 2016 | Sale | $20.01 | 2,500 | 50,021 | 20,642 | Jan 12, 2016, 05:38 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jan 06, 2016 | Sale | $22.28 | 2,161 | 48,139 | 20,712 | Jan 08, 2016, 07:27 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jan 07, 2016 | Sale | $21.33 | 1 | 21 | 20,642 | Jan 08, 2016, 07:27 PM |
| Gurney Austin | See Remarks | Jan 07, 2016 | Sale | $21.33 | 1 | 21 | 33,257 | Jan 08, 2016, 07:26 PM |
| Gurney Austin | See Remarks | Jan 06, 2016 | Sale | $22.28 | 2,161 | 48,139 | 33,327 | Jan 08, 2016, 07:26 PM |
| Hoey Timothy | SVP, Cancer Biology | Jan 07, 2016 | Sale | $21.33 | 1 | 21 | 47,181 | Jan 08, 2016, 07:26 PM |
| Hoey Timothy | SVP, Cancer Biology | Jan 06, 2016 | Sale | $22.28 | 2,161 | 48,141 | 47,251 | Jan 08, 2016, 07:26 PM |
| HASTINGS PAUL J | Chairman & CEO | Jan 06, 2016 | Sale | $22.28 | 2,412 | 53,731 | 22,102 | Jan 08, 2016, 07:25 PM |
| Hager Alicia J. | VP & General Counsel | Jan 07, 2016 | Sale | $21.33 | 1 | 21 | 13,377 | Jan 08, 2016, 07:25 PM |
| Hager Alicia J. | VP & General Counsel | Jan 06, 2016 | Sale | $22.28 | 1,622 | 36,132 | 13,430 | Jan 08, 2016, 07:25 PM |
| Patel Sunil | See Remarks | Jan 07, 2016 | Sale | $21.33 | 1 | 21 | 17,838 | Jan 08, 2016, 07:24 PM |
| Patel Sunil | See Remarks | Jan 06, 2016 | Sale | $22.28 | 2,161 | 48,147 | 17,908 | Jan 08, 2016, 07:24 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Jan 07, 2016 | Sale | $21.33 | 1 | 21 | 17,838 | Jan 08, 2016, 07:24 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Jan 06, 2016 | Sale | $22.28 | 2,161 | 48,141 | 17,908 | Jan 08, 2016, 07:24 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Dec 10, 2015 | Option Exercise | $4.56 | 2,500 | 11,400 | 25,304 | Dec 14, 2015, 05:02 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Dec 10, 2015 | Sale | $20.49 | 2,500 | 51,231 | 22,804 | Dec 14, 2015, 05:02 PM |
| Hager Alicia J. | VP & General Counsel | Nov 27, 2015 | Option Exercise | $3.42 | 1,800 | 6,156 | 16,800 | Dec 01, 2015, 05:19 PM |
| Hager Alicia J. | VP & General Counsel | Nov 27, 2015 | Sale | $23.14 | 1,800 | 41,654 | 15,000 | Dec 01, 2015, 05:19 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Nov 10, 2015 | Option Exercise | $4.56 | 2,500 | 11,400 | 25,304 | Nov 12, 2015, 06:48 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Nov 10, 2015 | Sale | $21.17 | 2,500 | 52,923 | 22,804 | Nov 12, 2015, 06:48 PM |
| Hager Alicia J. | VP & General Counsel | Oct 27, 2015 | Option Exercise | $3.42 | 5,400 | 18,468 | 20,400 | Oct 29, 2015, 07:49 PM |
| Hager Alicia J. | VP & General Counsel | Oct 27, 2015 | Sale | $21.00 | 5,400 | 113,400 | 15,000 | Oct 29, 2015, 07:49 PM |
| Gurney Austin | See Remarks | Oct 26, 2015 | Sale | $20.00 | 14,000 | 280,000 | 35,419 | Oct 27, 2015, 07:15 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Oct 26, 2015 | Option Exercise | $4.56 | 5,000 | 22,800 | 27,804 | Oct 27, 2015, 07:14 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Oct 26, 2015 | Sale | $20.00 | 5,000 | 100,000 | 22,804 | Oct 27, 2015, 07:14 PM |
| LASERSOHN JACK W | Director | Sep 30, 2015 | Buy | $16.01 | 11,210 | 179,512 | 46,560 | Oct 01, 2015, 07:39 PM |
| LASERSOHN JACK W | Director | Sep 29, 2015 | Buy | $14.15 | 3,140 | 44,431 | 35,350 | Sep 30, 2015, 07:54 PM |
| LASERSOHN JACK W | Director | Sep 28, 2015 | Buy | $14.74 | 10,000 | 147,353 | 32,210 | Sep 30, 2015, 07:54 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Aug 10, 2015 | Option Exercise | $4.56 | 2,500 | 11,400 | 24,877 | Aug 12, 2015, 07:14 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Aug 10, 2015 | Sale | $22.25 | 2,500 | 55,622 | 22,377 | Aug 12, 2015, 07:14 PM |
| Gurney Austin | See Remarks | Jul 30, 2015 | Sale | $21.09 | 7,000 | 147,601 | 50,518 | Jul 31, 2015, 04:21 PM |
| Gurney Austin | See Remarks | Jul 29, 2015 | Sale | $20.68 | 7,000 | 144,758 | 56,419 | Jul 31, 2015, 04:21 PM |
| Hager Alicia J. | VP & General Counsel | Jul 28, 2015 | Option Exercise | $3.42 | 1,800 | 6,156 | 16,800 | Jul 29, 2015, 04:57 PM |
| Hager Alicia J. | VP & General Counsel | Jul 28, 2015 | Sale | $21.00 | 1,800 | 37,800 | 15,000 | Jul 29, 2015, 04:57 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jul 10, 2015 | Option Exercise | $4.56 | 2,500 | 11,400 | 24,877 | Jul 13, 2015, 05:28 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jul 10, 2015 | Sale | $20.13 | 2,500 | 50,325 | 22,377 | Jul 13, 2015, 05:28 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jul 06, 2015 | Option Exercise | $4.56 | 2,500 | 11,400 | 24,877 | Jul 07, 2015, 05:06 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jul 06, 2015 | Sale | $21.22 | 2,500 | 53,050 | 22,377 | Jul 07, 2015, 05:06 PM |
| Hager Alicia J. | VP & General Counsel | Jun 29, 2015 | Option Exercise | $3.42 | 1,800 | 6,156 | 16,800 | Jun 30, 2015, 05:17 PM |
| Hager Alicia J. | VP & General Counsel | Jun 29, 2015 | Sale | $22.67 | 1,800 | 40,798 | 15,000 | Jun 30, 2015, 05:17 PM |
| Hoey Timothy | SVP, Cancer Biology | Jun 22, 2015 | Option Exercise | $1.43 | 5,000 | 7,150 | 54,343 | Jun 24, 2015, 04:12 PM |
| Hoey Timothy | SVP, Cancer Biology | Jun 22, 2015 | Sale | $26.07 | 5,000 | 130,337 | 49,343 | Jun 24, 2015, 04:12 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Jun 15, 2015 | Option Exercise | $1.43 | 8,500 | 12,155 | 28,500 | Jun 17, 2015, 05:49 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Jun 16, 2015 | Option Exercise | $2.11 | 8,500 | 17,922 | 28,500 | Jun 17, 2015, 05:49 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Jun 15, 2015 | Sale | $24.92 | 8,500 | 211,792 | 20,000 | Jun 17, 2015, 05:49 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Jun 16, 2015 | Sale | $25.22 | 8,500 | 214,333 | 20,000 | Jun 17, 2015, 05:49 PM |
| Hager Alicia J. | VP & General Counsel | May 27, 2015 | Option Exercise | $3.42 | 1,800 | 6,156 | 16,800 | May 28, 2015, 07:05 PM |
| Hager Alicia J. | VP & General Counsel | May 27, 2015 | Sale | $23.07 | 1,800 | 41,527 | 15,000 | May 28, 2015, 07:05 PM |
| Gurney Austin | See Remarks | May 18, 2015 | Sale | $22.47 | 4,000 | 89,900 | 63,519 | May 20, 2015, 08:12 PM |
| Hager Alicia J. | VP & General Counsel | Apr 27, 2015 | Option Exercise | $3.42 | 1,800 | 6,156 | 16,800 | Apr 29, 2015, 05:44 PM |
| Hager Alicia J. | VP & General Counsel | Apr 27, 2015 | Sale | $25.65 | 1,800 | 46,172 | 15,855 | Apr 29, 2015, 05:44 PM |
| Hoey Timothy | SVP, Cancer Biology | Apr 27, 2015 | Option Exercise | $1.43 | 5,000 | 7,150 | 56,230 | Apr 29, 2015, 05:43 PM |
| Hoey Timothy | SVP, Cancer Biology | Apr 27, 2015 | Sale | $25.65 | 6,887 | 176,645 | 52,693 | Apr 29, 2015, 05:43 PM |
| Gurney Austin | See Remarks | Apr 17, 2015 | Sale | $25.51 | 4,000 | 102,049 | 67,569 | Apr 20, 2015, 07:18 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Apr 10, 2015 | Option Exercise | $4.56 | 1,500 | 6,840 | 23,877 | Apr 14, 2015, 03:00 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Apr 10, 2015 | Sale | $26.51 | 1,500 | 39,765 | 22,377 | Apr 14, 2015, 03:00 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Apr 02, 2015 | Option Exercise | $1.43 | 8,500 | 12,155 | 29,785 | Apr 03, 2015, 03:42 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Apr 01, 2015 | Option Exercise | $1.43 | 8,500 | 12,155 | 29,785 | Apr 03, 2015, 03:42 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Apr 02, 2015 | Sale | $25.37 | 8,500 | 215,604 | 22,845 | Apr 03, 2015, 03:42 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Apr 01, 2015 | Sale | $25.19 | 8,500 | 214,105 | 21,285 | Apr 03, 2015, 03:42 PM |
| Patel Sunil | See Remarks | Mar 20, 2015 | Option Exercise | $3.42 | 14,665 | 50,154 | 34,665 | Mar 23, 2015, 08:31 PM |
| Patel Sunil | See Remarks | Mar 19, 2015 | Option Exercise | $3.42 | 3,335 | 11,406 | 23,335 | Mar 23, 2015, 08:31 PM |
| Patel Sunil | See Remarks | Mar 20, 2015 | Sale | $27.86 | 14,665 | 408,543 | 20,000 | Mar 23, 2015, 08:31 PM |
| Patel Sunil | See Remarks | Mar 19, 2015 | Sale | $27.34 | 3,335 | 91,186 | 20,000 | Mar 23, 2015, 08:31 PM |
| Gurney Austin | See Remarks | Mar 17, 2015 | Sale | $27.37 | 4,000 | 109,470 | 71,419 | Mar 19, 2015, 05:43 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Mar 10, 2015 | Option Exercise | $4.56 | 1,500 | 6,840 | 23,120 | Mar 12, 2015, 08:00 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Mar 10, 2015 | Sale | $27.17 | 1,500 | 40,754 | 21,620 | Mar 12, 2015, 08:00 PM |
| Gurney Austin | See Remarks | Feb 17, 2015 | Sale | $26.37 | 4,000 | 105,493 | 74,134 | Feb 19, 2015, 07:39 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Feb 10, 2015 | Option Exercise | $4.56 | 1,500 | 6,840 | 23,120 | Feb 12, 2015, 05:34 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Feb 10, 2015 | Sale | $24.23 | 1,500 | 36,351 | 21,620 | Feb 12, 2015, 05:34 PM |
| Hoey Timothy | SVP, Cancer Biology | Feb 05, 2015 | Option Exercise | $1.43 | 7,500 | 10,725 | 57,445 | Feb 09, 2015, 05:45 PM |
| Hoey Timothy | SVP, Cancer Biology | Feb 05, 2015 | Sale | $22.83 | 7,500 | 171,239 | 49,945 | Feb 09, 2015, 05:45 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Feb 02, 2015 | Option Exercise | $1.43 | 4,000 | 5,720 | 24,000 | Feb 04, 2015, 01:34 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Feb 02, 2015 | Sale | $22.49 | 4,000 | 89,951 | 20,000 | Feb 04, 2015, 01:34 PM |
| Gurney Austin | See Remarks | Jan 20, 2015 | Sale | $22.87 | 4,000 | 91,476 | 78,234 | Jan 21, 2015, 09:36 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jan 12, 2015 | Option Exercise | $4.56 | 1,500 | 6,840 | 23,120 | Jan 14, 2015, 05:45 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jan 12, 2015 | Sale | $25.89 | 1,500 | 38,836 | 22,020 | Jan 14, 2015, 05:45 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jan 05, 2015 | Option Exercise | $4.56 | 7,500 | 34,200 | 29,120 | Jan 07, 2015, 04:03 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jan 05, 2015 | Sale | $23.00 | 7,500 | 172,500 | 21,620 | Jan 07, 2015, 04:03 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Jan 02, 2015 | Option Exercise | $1.43 | 4,000 | 5,720 | 24,000 | Jan 05, 2015, 08:24 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Jan 02, 2015 | Sale | $22.10 | 4,000 | 88,408 | 20,400 | Jan 05, 2015, 08:24 PM |
| Pollard-Knight Denise | Director | Dec 31, 2014 | Sale | $21.66 | 3,799 | 82,300 | 1,943,509 | Jan 02, 2015, 03:33 PM |
| Pollard-Knight Denise | Director | Dec 30, 2014 | Sale | $21.65 | 5,510 | 119,286 | 1,947,308 | Dec 30, 2014, 07:37 PM |
| Pollard-Knight Denise | Director | Dec 29, 2014 | Sale | $21.62 | 9,902 | 214,048 | 1,952,818 | Dec 30, 2014, 07:37 PM |
| Pollard-Knight Denise | Director | Dec 26, 2014 | Sale | $21.65 | 2,195 | 47,516 | 1,962,720 | Dec 30, 2014, 07:37 PM |
| Pollard-Knight Denise | Director | Dec 19, 2014 | Sale | $21.71 | 20,654 | 448,310 | 1,964,915 | Dec 23, 2014, 05:10 PM |
| Gurney Austin | See Remarks | Dec 17, 2014 | Sale | $20.00 | 4,000 | 80,000 | 82,134 | Dec 19, 2014, 02:01 PM |
| ROOT JONATHAN D | Director | Dec 18, 2014 | Sale | $21.05 | 4,390 | 92,423 | 9,509 | Dec 19, 2014, 01:36 PM |
| ROOT JONATHAN D | Director | Dec 18, 2014 | Sale | $21.05 | 8,662 | 182,361 | 18,758 | Dec 19, 2014, 01:36 PM |
| Pollard-Knight Denise | Director | Dec 08, 2014 | Sale | $21.68 | 1,727 | 37,435 | 2,016,782 | Dec 10, 2014, 07:23 PM |
| Pollard-Knight Denise | Director | Dec 10, 2014 | Sale | $21.77 | 7,940 | 172,889 | 1,985,569 | Dec 10, 2014, 07:23 PM |
| Pollard-Knight Denise | Director | Dec 09, 2014 | Sale | $21.78 | 23,273 | 506,970 | 1,993,509 | Dec 10, 2014, 07:23 PM |
| Pollard-Knight Denise | Director | Dec 05, 2014 | Sale | $21.60 | 25,000 | 539,951 | 2,019,264 | Dec 05, 2014, 06:59 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Dec 01, 2014 | Option Exercise | $1.43 | 4,000 | 5,720 | 24,000 | Dec 03, 2014, 03:23 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Dec 01, 2014 | Sale | $21.19 | 4,000 | 84,752 | 20,000 | Dec 03, 2014, 03:23 PM |
| Gurney Austin | See Remarks | Nov 17, 2014 | Sale | $20.16 | 4,000 | 80,659 | 86,134 | Nov 19, 2014, 04:09 PM |
| Hoey Timothy | SVP, Cancer Biology | Nov 05, 2014 | Option Exercise | $1.43 | 2,500 | 3,575 | 52,445 | Nov 07, 2014, 01:42 PM |
| Hoey Timothy | SVP, Cancer Biology | Nov 05, 2014 | Sale | $19.51 | 2,500 | 48,766 | 49,945 | Nov 07, 2014, 01:42 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Nov 03, 2014 | Option Exercise | $1.43 | 4,000 | 5,720 | 24,000 | Nov 05, 2014, 07:28 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Nov 03, 2014 | Sale | $20.45 | 4,000 | 81,818 | 20,000 | Nov 05, 2014, 07:28 PM |
| HASTINGS PAUL J | Chairman & CEO | Oct 29, 2014 | Option Exercise | $1.43 | 8,385 | 11,991 | 31,616 | Oct 30, 2014, 07:27 PM |
| HASTINGS PAUL J | Chairman & CEO | Oct 28, 2014 | Option Exercise | $1.43 | 8,384 | 11,989 | 31,615 | Oct 30, 2014, 07:27 PM |
| HASTINGS PAUL J | Chairman & CEO | Oct 29, 2014 | Sale | $21.90 | 8,385 | 183,618 | 23,231 | Oct 30, 2014, 07:27 PM |
| HASTINGS PAUL J | Chairman & CEO | Oct 28, 2014 | Sale | $22.08 | 8,384 | 185,124 | 23,231 | Oct 30, 2014, 07:27 PM |
| Gurney Austin | See Remarks | Oct 17, 2014 | Sale | $20.07 | 4,000 | 80,280 | 90,134 | Oct 20, 2014, 03:39 PM |
| Gurney Austin | See Remarks | Oct 02, 2014 | Sale | $20.00 | 4,000 | 80,000 | 94,134 | Oct 03, 2014, 02:35 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Oct 02, 2014 | Option Exercise | $1.43 | 5,809 | 8,307 | 26,411 | Oct 03, 2014, 02:35 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Oct 02, 2014 | Sale | $20.00 | 5,809 | 116,180 | 20,602 | Oct 03, 2014, 02:35 PM |
| LASERSOHN JACK W | Director | Sep 04, 2014 | Buy | $17.50 | 170 | 2,975 | 4,215 | Sep 05, 2014, 06:07 PM |
| LASERSOHN JACK W | Director | Sep 03, 2014 | Buy | $18.40 | 3,000 | 55,199 | 4,045 | Sep 05, 2014, 06:07 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Sep 02, 2014 | Option Exercise | $1.43 | 2,191 | 3,133 | 22,793 | Sep 03, 2014, 03:03 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Sep 02, 2014 | Sale | $20.00 | 2,191 | 43,831 | 20,602 | Sep 03, 2014, 03:03 PM |
| Gurney Austin | See Remarks | Aug 22, 2014 | Sale | $20.00 | 4,000 | 80,000 | 97,532 | Aug 25, 2014, 05:10 PM |
| PAKIANATHAN DEEPIKA | Director | Aug 20, 2014 | Buy | $19.00 | 45,630 | 866,847 | 1,970,200 | Aug 21, 2014, 07:47 PM |
| PAKIANATHAN DEEPIKA | Director | Aug 19, 2014 | Buy | $18.89 | 116 | 2,191 | 18,310 | Aug 21, 2014, 07:47 PM |
| PAKIANATHAN DEEPIKA | Director | Aug 19, 2014 | Buy | $18.89 | 12,425 | 234,698 | 1,924,570 | Aug 21, 2014, 07:47 PM |
| PAKIANATHAN DEEPIKA | Director | Aug 21, 2014 | Buy | $18.98 | 201 | 3,815 | 18,940 | Aug 21, 2014, 07:47 PM |
| PAKIANATHAN DEEPIKA | Director | Aug 21, 2014 | Buy | $18.98 | 21,402 | 406,171 | 1,991,602 | Aug 21, 2014, 07:47 PM |
| PAKIANATHAN DEEPIKA | Director | Aug 20, 2014 | Buy | $19.00 | 429 | 8,150 | 18,739 | Aug 21, 2014, 07:47 PM |
| LASERSOHN JACK W | Director | Aug 15, 2014 | Buy | $17.00 | 1,045 | 17,765 | 1,045 | Aug 19, 2014, 04:51 PM |
| Hoey Timothy | SVP, Cancer Biology | Aug 05, 2014 | Option Exercise | $1.43 | 2,500 | 3,575 | 51,843 | Aug 07, 2014, 04:06 PM |
| Hoey Timothy | SVP, Cancer Biology | Aug 05, 2014 | Sale | $21.66 | 2,500 | 54,156 | 49,543 | Aug 07, 2014, 04:06 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Aug 01, 2014 | Option Exercise | $1.43 | 4,000 | 5,720 | 24,000 | Aug 04, 2014, 05:38 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Aug 01, 2014 | Sale | $20.98 | 4,000 | 83,912 | 20,000 | Aug 04, 2014, 05:38 PM |
| HASTINGS PAUL J | Chairman & CEO | Jul 29, 2014 | Option Exercise | $1.43 | 8,385 | 11,991 | 30,885 | Jul 30, 2014, 07:53 PM |
| HASTINGS PAUL J | Chairman & CEO | Jul 28, 2014 | Option Exercise | $1.43 | 8,385 | 11,991 | 30,885 | Jul 30, 2014, 07:53 PM |
| HASTINGS PAUL J | Chairman & CEO | Jul 29, 2014 | Sale | $22.28 | 8,385 | 186,802 | 22,500 | Jul 30, 2014, 07:53 PM |
| HASTINGS PAUL J | Chairman & CEO | Jul 28, 2014 | Sale | $21.94 | 8,385 | 183,936 | 22,600 | Jul 30, 2014, 07:53 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jul 23, 2014 | Option Exercise | $4.56 | 1,500 | 6,840 | 22,396 | Jul 25, 2014, 06:24 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jul 23, 2014 | Sale | $23.00 | 1,500 | 34,500 | 20,896 | Jul 25, 2014, 06:24 PM |
| Gurney Austin | See Remarks | Jul 17, 2014 | Sale | $20.46 | 4,000 | 81,853 | 101,532 | Jul 18, 2014, 08:16 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Jul 01, 2014 | Option Exercise | $1.43 | 4,000 | 5,720 | 24,000 | Jul 03, 2014, 01:17 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Jul 01, 2014 | Sale | $23.86 | 4,000 | 95,434 | 20,704 | Jul 03, 2014, 01:17 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Jun 16, 2014 | Sale | $24.59 | 4,000 | 98,348 | 22,638 | Jul 03, 2014, 01:16 PM |
| Pollard-Knight Denise | Director | Jun 30, 2014 | Sale | $23.59 | 11,485 | 270,919 | 2,043,509 | Jul 02, 2014, 01:40 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jun 26, 2014 | Option Exercise | $4.56 | 1,500 | 6,840 | 22,396 | Jun 30, 2014, 07:51 PM |
| Dupont Jakob | SVP & Chief Medical Officer | Jun 26, 2014 | Sale | $23.00 | 1,500 | 34,503 | 20,896 | Jun 30, 2014, 07:51 PM |
| Pollard-Knight Denise | Director | Jun 25, 2014 | Sale | $23.56 | 3,252 | 76,624 | 2,054,994 | Jun 27, 2014, 01:56 PM |
| Pollard-Knight Denise | Director | Jun 24, 2014 | Sale | $23.57 | 11,764 | 277,320 | 2,058,246 | Jun 25, 2014, 05:25 PM |
| Pollard-Knight Denise | Director | Jun 23, 2014 | Sale | $24.20 | 52,797 | 1,277,429 | 2,070,010 | Jun 25, 2014, 05:25 PM |
| Gurney Austin | See Remarks | Jun 17, 2014 | Sale | $24.99 | 4,000 | 99,965 | 105,532 | Jun 18, 2014, 07:50 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Jun 16, 2014 | Option Exercise | $1.43 | 4,000 | 5,720 | 24,000 | Jun 17, 2014, 07:55 PM |
| Lewicki John A. | EVP & Chief Scientific Officer | Jun 16, 2014 | Sale | $24.59 | 4,000 | 98,348 | 20,000 | Jun 17, 2014, 07:55 PM |
| ROOT JONATHAN D | Director | Jun 09, 2014 | Sale | $24.62 | 5,476 | 134,819 | 30,606 | Jun 11, 2014, 05:29 PM |
| ROOT JONATHAN D | Director | Jun 10, 2014 | Sale | $24.48 | 1,614 | 39,511 | 11,123 | Jun 11, 2014, 05:29 PM |
| ROOT JONATHAN D | Director | Jun 10, 2014 | Sale | $24.48 | 3,186 | 77,993 | 21,944 | Jun 11, 2014, 05:29 PM |
| ROOT JONATHAN D | Director | Jun 09, 2014 | Sale | $24.62 | 2,776 | 68,345 | 15,513 | Jun 11, 2014, 05:29 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | Jun 10, 2014 | Sale | $24.48 | 1,614 | 39,511 | 11,123 | Jun 11, 2014, 05:27 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | Jun 10, 2014 | Sale | $24.48 | 3,186 | 77,993 | 21,944 | Jun 11, 2014, 05:27 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | Jun 09, 2014 | Sale | $24.62 | 2,776 | 68,345 | 15,513 | Jun 11, 2014, 05:27 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | Jun 09, 2014 | Sale | $24.62 | 5,476 | 134,819 | 30,606 | Jun 11, 2014, 05:27 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | May 15, 2014 | Sale | $22.51 | 28,956 | 651,800 | 0 | May 19, 2014, 05:59 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | May 12, 2014 | Sale | $21.98 | 17,371 | 381,815 | 17,382 | May 13, 2014, 07:41 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | May 12, 2014 | Sale | $21.99 | 28,956 | 636,742 | 0 | May 13, 2014, 07:41 PM |
| Hoey Timothy | SVP, Cancer Biology | May 05, 2014 | Option Exercise | $1.43 | 2,500 | 3,575 | 51,843 | May 07, 2014, 07:45 PM |
| Hoey Timothy | SVP, Cancer Biology | May 05, 2014 | Sale | $26.41 | 2,500 | 66,019 | 49,343 | May 07, 2014, 07:45 PM |
| Hoey Timothy | SVP, Cancer Biology | Mar 05, 2014 | Sale | $35.81 | 1,792 | 64,180 | 29,343 | Mar 07, 2014, 05:46 PM |
| Hoey Timothy | SVP, Cancer Biology | Feb 05, 2014 | Option Exercise | $1.43 | 5,000 | 7,150 | 34,343 | Feb 07, 2014, 06:19 PM |
| Hoey Timothy | SVP, Cancer Biology | Feb 05, 2014 | Sale | $30.10 | 5,000 | 150,512 | 29,743 | Feb 07, 2014, 06:19 PM |
| MORGENTHALER PARTNERS VII LP | 10% Owner | Jul 23, 2013 | Buy | $17.00 | 70,588 | 1,199,996 | 2,509,671 | Jul 23, 2013, 07:12 PM |
| LVP GP I, LLC | 10% Owner | Jul 23, 2013 | Buy | $17.00 | 1,080 | 18,360 | 33,703 | Jul 23, 2013, 07:11 PM |
| LVP GP I, LLC | 10% Owner | Jul 23, 2013 | Buy | $17.00 | 2,161 | 36,737 | 67,409 | Jul 23, 2013, 07:11 PM |
| LVP GP I, LLC | 10% Owner | Jul 23, 2013 | Buy | $17.00 | 43,223 | 734,791 | 1,348,212 | Jul 23, 2013, 07:11 PM |
| LVP GP I, LLC | 10% Owner | Jul 23, 2013 | Buy | $17.00 | 33,834 | 575,178 | 1,055,363 | Jul 23, 2013, 07:11 PM |
| LVP GP I, LLC | 10% Owner | Jul 23, 2013 | Buy | $17.00 | 7,937 | 134,929 | 247,555 | Jul 23, 2013, 07:11 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | Jul 23, 2013 | Buy | $17.00 | 727 | 12,359 | 18,289 | Jul 23, 2013, 07:11 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | Jul 23, 2013 | Buy | $17.00 | 1,434 | 24,378 | 36,082 | Jul 23, 2013, 07:11 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | Jul 23, 2013 | Buy | $17.00 | 155,164 | 2,637,788 | 3,903,984 | Jul 23, 2013, 07:11 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | Jul 23, 2013 | Buy | $17.00 | 1,498 | 25,466 | 37,682 | Jul 23, 2013, 07:11 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | Jul 23, 2013 | Buy | $17.00 | 155,164 | 2,637,788 | 3,903,984 | Jul 23, 2013, 07:10 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | Jul 23, 2013 | Buy | $17.00 | 1,498 | 25,466 | 37,682 | Jul 23, 2013, 07:10 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | Jul 23, 2013 | Buy | $17.00 | 727 | 12,359 | 18,289 | Jul 23, 2013, 07:10 PM |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | Jul 23, 2013 | Buy | $17.00 | 1,434 | 24,378 | 36,082 | Jul 23, 2013, 07:10 PM |
| Woody James N. | Director | Jul 23, 2013 | Buy | $17.00 | 1,080 | 18,360 | 33,703 | Jul 23, 2013, 07:09 PM |
| Woody James N. | Director | Jul 23, 2013 | Buy | $17.00 | 2,161 | 36,737 | 67,409 | Jul 23, 2013, 07:09 PM |
| Woody James N. | Director | Jul 23, 2013 | Buy | $17.00 | 43,223 | 734,791 | 1,348,212 | Jul 23, 2013, 07:09 PM |
| Woody James N. | Director | Jul 23, 2013 | Buy | $17.00 | 33,834 | 575,178 | 1,055,363 | Jul 23, 2013, 07:09 PM |
| Woody James N. | Director | Jul 23, 2013 | Buy | $17.00 | 7,937 | 134,929 | 247,555 | Jul 23, 2013, 07:09 PM |
| ROOT JONATHAN D | Director | Jul 23, 2013 | Buy | $17.00 | 1,498 | 25,466 | 37,682 | Jul 23, 2013, 07:09 PM |
| ROOT JONATHAN D | Director | Jul 23, 2013 | Buy | $17.00 | 727 | 12,359 | 18,289 | Jul 23, 2013, 07:09 PM |
| ROOT JONATHAN D | Director | Jul 23, 2013 | Buy | $17.00 | 1,434 | 24,378 | 36,082 | Jul 23, 2013, 07:09 PM |
| ROOT JONATHAN D | Director | Jul 23, 2013 | Buy | $17.00 | 155,164 | 2,637,788 | 3,903,984 | Jul 23, 2013, 07:09 PM |
| Broderick James W. | Director | Jul 23, 2013 | Buy | $17.00 | 70,588 | 1,199,996 | 2,509,671 | Jul 23, 2013, 07:08 PM |
| PAKIANATHAN DEEPIKA | Director | Jul 23, 2013 | Buy | $17.00 | 379,127 | 6,445,159 | 1,912,145 | Jul 23, 2013, 07:07 PM |
| PAKIANATHAN DEEPIKA | Director | Jul 23, 2013 | Buy | $17.00 | 3,226 | 54,842 | 18,194 | Jul 23, 2013, 07:07 PM |
| Pollard-Knight Denise | Director | Jul 23, 2013 | Buy | $17.00 | 58,824 | 1,000,008 | 2,122,807 | Jul 23, 2013, 07:07 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Gurney Austin | See Remarks | 12/24/2018 | 6,669 |
| Stagg Robert | SVP, Clinical R&D | 10/10/2018 | 1,863 |
| Li Yvonne | See Remarks | 10/10/2018 | 1,873 |
| Gurney Austin | See Remarks | 10/10/2018 | 2,324 |
| Hager Alicia J. | SVP & General Counsel | 10/10/2018 | 2,335 |
| Lewicki John A. | President & CEO | 10/10/2018 | 2,324 |
| Li Yvonne | See Remarks | 10/09/2018 | 2,616 |
| Gurney Austin | See Remarks | 10/09/2018 | 3,589 |
| Stagg Robert | SVP, Clinical R&D | 10/09/2018 | 3,589 |
| Lewicki John A. | President & CEO | 10/09/2018 | 4,888 |
| Hager Alicia J. | SVP & General Counsel | 10/09/2018 | 3,589 |
| Li Yvonne | See Remarks | 04/24/2018 | 13,555 |
| Stagg Robert | SVP, Clinical R&D | 04/24/2018 | 10,848 |
| Lewicki John A. | President & CEO | 04/24/2018 | 12,202 |
| Gurney Austin | See Remarks | 04/24/2018 | 10,848 |
| Hager Alicia J. | SVP & General Counsel | 04/24/2018 | 10,848 |
| Patel Sunil | See Remarks | 10/10/2017 | 5,295 |
| HASTINGS PAUL J | Chairman & CEO | 10/10/2017 | 5,931 |
| Lewicki John A. | EVP, Research & Development | 10/10/2017 | 5,295 |
| Gurney Austin | See Remarks | 10/10/2017 | 5,295 |
| Hager Alicia J. | SVP & General Counsel | 10/10/2017 | 5,295 |
| KARSEN PERRY A | Director | 06/05/2017 | 34,588 |
| LASERSOHN JACK W | Director | 05/25/2017 | 116,639 |
| ROOT JONATHAN D | Director | 05/24/2017 | 5,377 |
| ROOT JONATHAN D | Director | 05/24/2017 | 10,601 |
| ROOT JONATHAN D | Director | 05/26/2017 | 11,927 |
| ROOT JONATHAN D | Director | 05/26/2017 | 23,536 |
| LASERSOHN JACK W | Director | 05/23/2017 | 71,000 |
| ROOT JONATHAN D | Director | 05/19/2017 | 9,324 |
| ROOT JONATHAN D | Director | 05/19/2017 | 18,388 |
| LASERSOHN JACK W | Director | 05/16/2017 | 82,061 |
| ROOT JONATHAN D | Director | 05/16/2017 | 8,313 |
| ROOT JONATHAN D | Director | 05/16/2017 | 16,401 |
| Lewicki John A. | EVP, Research & Development | 04/04/2017 | 52,113 |
| Gurney Austin | See Remarks | 04/04/2017 | 52,113 |
| Patel Sunil | See Remarks | 04/04/2017 | 52,113 |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | 04/04/2017 | 52,113 |
| Hager Alicia J. | SVP & General Counsel | 04/04/2017 | 39,089 |
| HASTINGS PAUL J | Chairman & CEO | 04/04/2017 | 58,625 |
| Hager Alicia J. | SVP & General Counsel | 03/15/2017 | 22,750 |
| Hager Alicia J. | SVP & General Counsel | 03/15/2017 | 66,520 |
| HASTINGS PAUL J | Chairman & CEO | 01/05/2017 | 30,558 |
| HASTINGS PAUL J | Chairman & CEO | 01/06/2017 | 30,558 |
| HASTINGS PAUL J | Chairman & CEO | 01/06/2017 | 181,957 |
| HASTINGS PAUL J | Chairman & CEO | 01/05/2017 | 174,602 |
| Lewicki John A. | EVP, Research & Development | 01/03/2017 | 13,120 |
| Lewicki John A. | EVP, Research & Development | 01/03/2017 | 70,045 |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | 01/03/2017 | 18,251 |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | 01/03/2017 | 97,448 |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | 11/16/2016 | 17,875 |
| Hoey Timothy | SVP, Cancer Biology & Co-CSO | 11/16/2016 | 123,609 |
| Dupont Jakob | SVP & Chief Medical Officer | 01/11/2016 | 11,400 |
| Dupont Jakob | SVP & Chief Medical Officer | 01/11/2016 | 50,021 |
| Dupont Jakob | SVP & Chief Medical Officer | 01/06/2016 | 48,139 |
| Dupont Jakob | SVP & Chief Medical Officer | 01/07/2016 | 21 |
| Gurney Austin | See Remarks | 01/07/2016 | 21 |
| Gurney Austin | See Remarks | 01/06/2016 | 48,139 |
| Hoey Timothy | SVP, Cancer Biology | 01/07/2016 | 21 |
| Hoey Timothy | SVP, Cancer Biology | 01/06/2016 | 48,141 |
| HASTINGS PAUL J | Chairman & CEO | 01/06/2016 | 53,731 |
| Hager Alicia J. | VP & General Counsel | 01/07/2016 | 21 |
| Hager Alicia J. | VP & General Counsel | 01/06/2016 | 36,132 |
| Patel Sunil | See Remarks | 01/07/2016 | 21 |
| Patel Sunil | See Remarks | 01/06/2016 | 48,147 |
| Lewicki John A. | EVP & Chief Scientific Officer | 01/07/2016 | 21 |
| Lewicki John A. | EVP & Chief Scientific Officer | 01/06/2016 | 48,141 |
| Dupont Jakob | SVP & Chief Medical Officer | 12/10/2015 | 11,400 |
| Dupont Jakob | SVP & Chief Medical Officer | 12/10/2015 | 51,231 |
| Hager Alicia J. | VP & General Counsel | 11/27/2015 | 6,156 |
| Hager Alicia J. | VP & General Counsel | 11/27/2015 | 41,654 |
| Dupont Jakob | SVP & Chief Medical Officer | 11/10/2015 | 11,400 |
| Dupont Jakob | SVP & Chief Medical Officer | 11/10/2015 | 52,923 |
| Hager Alicia J. | VP & General Counsel | 10/27/2015 | 18,468 |
| Hager Alicia J. | VP & General Counsel | 10/27/2015 | 113,400 |
| Gurney Austin | See Remarks | 10/26/2015 | 280,000 |
| Dupont Jakob | SVP & Chief Medical Officer | 10/26/2015 | 22,800 |
| Dupont Jakob | SVP & Chief Medical Officer | 10/26/2015 | 100,000 |
| LASERSOHN JACK W | Director | 09/30/2015 | 179,512 |
| LASERSOHN JACK W | Director | 09/29/2015 | 44,431 |
| LASERSOHN JACK W | Director | 09/28/2015 | 147,353 |
| Dupont Jakob | SVP & Chief Medical Officer | 08/10/2015 | 11,400 |
| Dupont Jakob | SVP & Chief Medical Officer | 08/10/2015 | 55,622 |
| Gurney Austin | See Remarks | 07/30/2015 | 147,601 |
| Gurney Austin | See Remarks | 07/29/2015 | 144,758 |
| Hager Alicia J. | VP & General Counsel | 07/28/2015 | 6,156 |
| Hager Alicia J. | VP & General Counsel | 07/28/2015 | 37,800 |
| Dupont Jakob | SVP & Chief Medical Officer | 07/10/2015 | 11,400 |
| Dupont Jakob | SVP & Chief Medical Officer | 07/10/2015 | 50,325 |
| Dupont Jakob | SVP & Chief Medical Officer | 07/06/2015 | 11,400 |
| Dupont Jakob | SVP & Chief Medical Officer | 07/06/2015 | 53,050 |
| Hager Alicia J. | VP & General Counsel | 06/29/2015 | 6,156 |
| Hager Alicia J. | VP & General Counsel | 06/29/2015 | 40,798 |
| Hoey Timothy | SVP, Cancer Biology | 06/22/2015 | 7,150 |
| Hoey Timothy | SVP, Cancer Biology | 06/22/2015 | 130,337 |
| Lewicki John A. | EVP & Chief Scientific Officer | 06/15/2015 | 12,155 |
| Lewicki John A. | EVP & Chief Scientific Officer | 06/16/2015 | 17,922 |
| Lewicki John A. | EVP & Chief Scientific Officer | 06/15/2015 | 211,792 |
| Lewicki John A. | EVP & Chief Scientific Officer | 06/16/2015 | 214,333 |
| Hager Alicia J. | VP & General Counsel | 05/27/2015 | 6,156 |
| Hager Alicia J. | VP & General Counsel | 05/27/2015 | 41,527 |
| Gurney Austin | See Remarks | 05/18/2015 | 89,900 |
| Hager Alicia J. | VP & General Counsel | 04/27/2015 | 6,156 |
| Hager Alicia J. | VP & General Counsel | 04/27/2015 | 46,172 |
| Hoey Timothy | SVP, Cancer Biology | 04/27/2015 | 7,150 |
| Hoey Timothy | SVP, Cancer Biology | 04/27/2015 | 176,645 |
| Gurney Austin | See Remarks | 04/17/2015 | 102,049 |
| Dupont Jakob | SVP & Chief Medical Officer | 04/10/2015 | 6,840 |
| Dupont Jakob | SVP & Chief Medical Officer | 04/10/2015 | 39,765 |
| Lewicki John A. | EVP & Chief Scientific Officer | 04/02/2015 | 12,155 |
| Lewicki John A. | EVP & Chief Scientific Officer | 04/01/2015 | 12,155 |
| Lewicki John A. | EVP & Chief Scientific Officer | 04/02/2015 | 215,604 |
| Lewicki John A. | EVP & Chief Scientific Officer | 04/01/2015 | 214,105 |
| Patel Sunil | See Remarks | 03/20/2015 | 50,154 |
| Patel Sunil | See Remarks | 03/19/2015 | 11,406 |
| Patel Sunil | See Remarks | 03/20/2015 | 408,543 |
| Patel Sunil | See Remarks | 03/19/2015 | 91,186 |
| Gurney Austin | See Remarks | 03/17/2015 | 109,470 |
| Dupont Jakob | SVP & Chief Medical Officer | 03/10/2015 | 6,840 |
| Dupont Jakob | SVP & Chief Medical Officer | 03/10/2015 | 40,754 |
| Gurney Austin | See Remarks | 02/17/2015 | 105,493 |
| Dupont Jakob | SVP & Chief Medical Officer | 02/10/2015 | 6,840 |
| Dupont Jakob | SVP & Chief Medical Officer | 02/10/2015 | 36,351 |
| Hoey Timothy | SVP, Cancer Biology | 02/05/2015 | 10,725 |
| Hoey Timothy | SVP, Cancer Biology | 02/05/2015 | 171,239 |
| Lewicki John A. | EVP & Chief Scientific Officer | 02/02/2015 | 5,720 |
| Lewicki John A. | EVP & Chief Scientific Officer | 02/02/2015 | 89,951 |
| Gurney Austin | See Remarks | 01/20/2015 | 91,476 |
| Dupont Jakob | SVP & Chief Medical Officer | 01/12/2015 | 6,840 |
| Dupont Jakob | SVP & Chief Medical Officer | 01/12/2015 | 38,836 |
| Dupont Jakob | SVP & Chief Medical Officer | 01/05/2015 | 34,200 |
| Dupont Jakob | SVP & Chief Medical Officer | 01/05/2015 | 172,500 |
| Lewicki John A. | EVP & Chief Scientific Officer | 01/02/2015 | 5,720 |
| Lewicki John A. | EVP & Chief Scientific Officer | 01/02/2015 | 88,408 |
| Pollard-Knight Denise | Director | 12/31/2014 | 82,300 |
| Pollard-Knight Denise | Director | 12/30/2014 | 119,286 |
| Pollard-Knight Denise | Director | 12/29/2014 | 214,048 |
| Pollard-Knight Denise | Director | 12/26/2014 | 47,516 |
| Pollard-Knight Denise | Director | 12/19/2014 | 448,310 |
| Gurney Austin | See Remarks | 12/17/2014 | 80,000 |
| ROOT JONATHAN D | Director | 12/18/2014 | 92,423 |
| ROOT JONATHAN D | Director | 12/18/2014 | 182,361 |
| Pollard-Knight Denise | Director | 12/08/2014 | 37,435 |
| Pollard-Knight Denise | Director | 12/10/2014 | 172,889 |
| Pollard-Knight Denise | Director | 12/09/2014 | 506,970 |
| Pollard-Knight Denise | Director | 12/05/2014 | 539,951 |
| Lewicki John A. | EVP & Chief Scientific Officer | 12/01/2014 | 5,720 |
| Lewicki John A. | EVP & Chief Scientific Officer | 12/01/2014 | 84,752 |
| Gurney Austin | See Remarks | 11/17/2014 | 80,659 |
| Hoey Timothy | SVP, Cancer Biology | 11/05/2014 | 3,575 |
| Hoey Timothy | SVP, Cancer Biology | 11/05/2014 | 48,766 |
| Lewicki John A. | EVP & Chief Scientific Officer | 11/03/2014 | 5,720 |
| Lewicki John A. | EVP & Chief Scientific Officer | 11/03/2014 | 81,818 |
| HASTINGS PAUL J | Chairman & CEO | 10/29/2014 | 11,991 |
| HASTINGS PAUL J | Chairman & CEO | 10/28/2014 | 11,989 |
| HASTINGS PAUL J | Chairman & CEO | 10/29/2014 | 183,618 |
| HASTINGS PAUL J | Chairman & CEO | 10/28/2014 | 185,124 |
| Gurney Austin | See Remarks | 10/17/2014 | 80,280 |
| Gurney Austin | See Remarks | 10/02/2014 | 80,000 |
| Lewicki John A. | EVP & Chief Scientific Officer | 10/02/2014 | 8,307 |
| Lewicki John A. | EVP & Chief Scientific Officer | 10/02/2014 | 116,180 |
| LASERSOHN JACK W | Director | 09/04/2014 | 2,975 |
| LASERSOHN JACK W | Director | 09/03/2014 | 55,199 |
| Lewicki John A. | EVP & Chief Scientific Officer | 09/02/2014 | 3,133 |
| Lewicki John A. | EVP & Chief Scientific Officer | 09/02/2014 | 43,831 |
| Gurney Austin | See Remarks | 08/22/2014 | 80,000 |
| PAKIANATHAN DEEPIKA | Director | 08/20/2014 | 866,847 |
| PAKIANATHAN DEEPIKA | Director | 08/19/2014 | 2,191 |
| PAKIANATHAN DEEPIKA | Director | 08/19/2014 | 234,698 |
| PAKIANATHAN DEEPIKA | Director | 08/21/2014 | 3,815 |
| PAKIANATHAN DEEPIKA | Director | 08/21/2014 | 406,171 |
| PAKIANATHAN DEEPIKA | Director | 08/20/2014 | 8,150 |
| LASERSOHN JACK W | Director | 08/15/2014 | 17,765 |
| Hoey Timothy | SVP, Cancer Biology | 08/05/2014 | 3,575 |
| Hoey Timothy | SVP, Cancer Biology | 08/05/2014 | 54,156 |
| Lewicki John A. | EVP & Chief Scientific Officer | 08/01/2014 | 5,720 |
| Lewicki John A. | EVP & Chief Scientific Officer | 08/01/2014 | 83,912 |
| HASTINGS PAUL J | Chairman & CEO | 07/29/2014 | 11,991 |
| HASTINGS PAUL J | Chairman & CEO | 07/28/2014 | 11,991 |
| HASTINGS PAUL J | Chairman & CEO | 07/29/2014 | 186,802 |
| HASTINGS PAUL J | Chairman & CEO | 07/28/2014 | 183,936 |
| Dupont Jakob | SVP & Chief Medical Officer | 07/23/2014 | 6,840 |
| Dupont Jakob | SVP & Chief Medical Officer | 07/23/2014 | 34,500 |
| Gurney Austin | See Remarks | 07/17/2014 | 81,853 |
| Lewicki John A. | EVP & Chief Scientific Officer | 07/01/2014 | 5,720 |
| Lewicki John A. | EVP & Chief Scientific Officer | 07/01/2014 | 95,434 |
| Lewicki John A. | EVP & Chief Scientific Officer | 06/16/2014 | 98,348 |
| Pollard-Knight Denise | Director | 06/30/2014 | 270,919 |
| Dupont Jakob | SVP & Chief Medical Officer | 06/26/2014 | 6,840 |
| Dupont Jakob | SVP & Chief Medical Officer | 06/26/2014 | 34,503 |
| Pollard-Knight Denise | Director | 06/25/2014 | 76,624 |
| Pollard-Knight Denise | Director | 06/24/2014 | 277,320 |
| Pollard-Knight Denise | Director | 06/23/2014 | 1,277,429 |
| Gurney Austin | See Remarks | 06/17/2014 | 99,965 |
| Lewicki John A. | EVP & Chief Scientific Officer | 06/16/2014 | 5,720 |
| Lewicki John A. | EVP & Chief Scientific Officer | 06/16/2014 | 98,348 |
| ROOT JONATHAN D | Director | 06/09/2014 | 134,819 |
| ROOT JONATHAN D | Director | 06/10/2014 | 39,511 |
| ROOT JONATHAN D | Director | 06/10/2014 | 77,993 |
| ROOT JONATHAN D | Director | 06/09/2014 | 68,345 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 06/10/2014 | 39,511 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 06/10/2014 | 77,993 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 06/09/2014 | 68,345 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 06/09/2014 | 134,819 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 05/15/2014 | 651,800 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 05/12/2014 | 381,815 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 05/12/2014 | 636,742 |
| Hoey Timothy | SVP, Cancer Biology | 05/05/2014 | 3,575 |
| Hoey Timothy | SVP, Cancer Biology | 05/05/2014 | 66,019 |
| Hoey Timothy | SVP, Cancer Biology | 03/05/2014 | 64,180 |
| Hoey Timothy | SVP, Cancer Biology | 02/05/2014 | 7,150 |
| Hoey Timothy | SVP, Cancer Biology | 02/05/2014 | 150,512 |
| MORGENTHALER PARTNERS VII LP | 10% Owner | 07/23/2013 | 1,199,996 |
| LVP GP I, LLC | 10% Owner | 07/23/2013 | 18,360 |
| LVP GP I, LLC | 10% Owner | 07/23/2013 | 36,737 |
| LVP GP I, LLC | 10% Owner | 07/23/2013 | 734,791 |
| LVP GP I, LLC | 10% Owner | 07/23/2013 | 575,178 |
| LVP GP I, LLC | 10% Owner | 07/23/2013 | 134,929 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 07/23/2013 | 12,359 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 07/23/2013 | 24,378 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 07/23/2013 | 2,637,788 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 07/23/2013 | 25,466 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 07/23/2013 | 2,637,788 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 07/23/2013 | 25,466 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 07/23/2013 | 12,359 |
| PRESIDIO MANAGEMENT GROUP VIII L L C | 10% Owner | 07/23/2013 | 24,378 |
| Woody James N. | Director | 07/23/2013 | 18,360 |
| Woody James N. | Director | 07/23/2013 | 36,737 |
| Woody James N. | Director | 07/23/2013 | 734,791 |
| Woody James N. | Director | 07/23/2013 | 575,178 |
| Woody James N. | Director | 07/23/2013 | 134,929 |
| ROOT JONATHAN D | Director | 07/23/2013 | 25,466 |
| ROOT JONATHAN D | Director | 07/23/2013 | 12,359 |
| ROOT JONATHAN D | Director | 07/23/2013 | 24,378 |
| ROOT JONATHAN D | Director | 07/23/2013 | 2,637,788 |
| Broderick James W. | Director | 07/23/2013 | 1,199,996 |
| PAKIANATHAN DEEPIKA | Director | 07/23/2013 | 6,445,159 |
| PAKIANATHAN DEEPIKA | Director | 07/23/2013 | 54,842 |
| Pollard-Knight Denise | Director | 07/23/2013 | 1,000,008 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR OPTMED INC
STOCK BUYBACKS FOR OPTMED INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2018
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2018
0.33%
2Q
12/31/2017
2.16%
4Q
09/30/2017
2.46%
5Q
06/30/2017
2.66%
6Q
03/31/2017
3.14%
7Q
12/31/2016
16.99%
8Q
09/30/2016
22.29%
9Q
06/30/2016
27.04%
10Q
03/31/2016
27.20%
11Q
12/31/2015
28.02%
12Q
Load More